Ask the Experts: A Lifelong Learning Series - October 2021

Disclosures:

Blumenthal, Scott L.: Consulting: Aesculap (C), Bayliss Medical (B), Degen Medical (C), NeoSpine (C), Orthofix (C); Device or Biologic Distribution Group (Physician-Owned Distributorship): Aesculap (A); Scientific Advisory Board: Aesculap (B), FzioMed (None); Speaking and/or Teaching Arrangements: Aesculap (D), Bayliss (None), NuVasive (None); Stock Ownership: Centinel Spine (1%), FzioMed (1%).

Guyer, Richard D.: Consulting: Aescalup (C), Orthofix (D), Spinal Kinetics (B); Royalties: ATEC (B), Nanovis (D), Stryker - K2M (B).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+